Search Site

Search form

Archived Press Releases

All Releases
View Summary Hepatitis C Virus Polymerase Inhibitor VX-222 Reduced Viral Levels Over Three Days in Phase 1b Trial
Apr 15, 2010
PDF 22.2 KB
View Summary 59 Percent of Patients Overall Achieved SVR with Telaprevir-Based Regimens in Study 107 After Not Achieving SVR with at Least One Prior Course of Treatment for Hepatitis C Virus Infection
Apr 15, 2010
PDF 21.9 KB
View Summary New England Journal of Medicine Publishes PROVE 3 Trial Showing Telaprevir-Based Regimens Significantly Increased Sustained Viral Response (SVR) Rates in Patients Who Did Not Achieve SVR with Prior HCV Therapy
Apr 7, 2010
PDF 22.2 KB
View Summary Vertex Pharmaceuticals Announces the Date of its First Quarter 2010 Financial Results Conference Call and Webcast
Apr 5, 2010
PDF 6.1 KB
View Summary Vertex Pharmaceuticals Announces Webcast of its Presentation at Canaccord Adams' Hepatitis C Conference
Mar 30, 2010
PDF 6.0 KB
View Summary Vertex Pharmaceuticals Announces Acceptance of Telaprevir and VX-222 Abstracts for Presentation at EASL Annual Meeting
Mar 16, 2010
PDF 12.9 KB
View Summary Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Mar 12, 2010
PDF 6.1 KB
View Summary Vertex Broadens its Commitment to Improving HCV Care with Clinical Trial to Evaluate Combination Regimens Based on Oral Antiviral Therapies
Mar 1, 2010
PDF 18.5 KB
View Summary Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Feb 25, 2010
PDF 6.3 KB
View Summary Vertex Pharmaceuticals Announces Redemption Date for 4.75% Convertible Senior Subordinated Notes due 2013
Feb 16, 2010
PDF 7.8 KB
View Summary Vertex Pharmaceuticals Reports 2009 Financial Results and Highlights Recent Progress in Hepatitis C and Cystic Fibrosis Development Programs
Feb 4, 2010
PDF 34.2 KB
View Summary Vertex Announces Results from Phase 2a Trial of VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
Feb 3, 2010
PDF 18.3 KB
View Summary Vertex Pharmaceuticals Announces the Date of its Full Year 2009 Financial Results Conference Call and Webcast
Jan 20, 2010
PDF 6.1 KB
View Summary Vertex Reviews 2010 Business Priorities to Support Goal of Becoming Fully-Capable Biopharmaceutical Company
Jan 10, 2010
PDF 25.7 KB
View Summary Vertex Pharmaceuticals Announces Webcast of its Presentation at the 28th Annual J.P. Morgan Healthcare Conference
Jan 5, 2010
PDF 6.1 KB
Showing 261-275 of 275 Page: 1 ... 10 11 12 13 14  Previous 20